Guidelines for Evaluation and Management of Pleural Effusion Identified by the Meniscus Sign

Radiographic Assessment

• On a lateral chest radiograph, blunting of the posterior costophrenic angle corresponds to approximately 26–50 mL of pleural fluid【1】.
• The meniscus sign becomes visible on a postero‑anterior (PA) radiograph when the fluid volume reaches roughly 100 mL, and the hemidiaphragm is obscured at 500–650 mL (derived from multiple sources, but only the 26–50 mL threshold is directly cited)【1】.

Ultrasound Evaluation

• Thoracic ultrasound can detect pleural effusions as small as 20 mL, making it more sensitive than plain radiography【2】.
• Ultrasound reliably distinguishes free‑flowing from loculated fluid【3】【1】.
• Septations are visualized more clearly on ultrasound than on CT【1】【4】.
• Pleural thickening and nodularity suggestive of malignancy are identifiable with ultrasound【3】.
• Ultrasound‑guided thoracentesis yields a 97 % success rate in loculated effusions【1】【4】.
• Sonographic patterns that predict an exudative effusion include complex septated, complex non‑septated, and homogeneously echogenic appearances (always exudates); hypoechoic effusions may be either transudate or exudate【1】【5】【4】.

Indications for Diagnostic Thoracentesis

• Perform thoracentesis when pleural fluid thickness exceeds 1 cm on chest radiograph or 2 cm on CT【6】【7】.
• Any parapneumonic effusion (effusion associated with pneumonia) warrants thoracentesis【6】【2】.
• Unilateral effusion of unknown etiology should be sampled diagnostically【1】.

Thoracentesis Technique and Safety

• Use ultrasound guidance for all thoracenteses to reduce procedural complications【1】【5】【6】.
• Collect pleural fluid in both sterile containers and blood‑culture bottles (aerobic and anaerobic) to maximize microbiologic yield【7】.
• Limit the initial therapeutic drainage to ≤1.5 L to avoid re‑expansion pulmonary edema【8】.

Pleural Fluid Analysis

• Measure pH in all non‑purulent effusions when infection is suspected; a pH < 7.2 indicates a complicated parapneumonic effusion that requires tube thoracostomy and possible surgery【7】.

Imaging (CT) Indications in Adults

• Obtain contrast‑enhanced CT when:

• Do not perform routine CT in pediatric patients because of high radiation exposure (up to 400 chest‑radiograph equivalents)【3】.

• Performing CT with pleural fluid present improves pleural visualization and helps identify optimal biopsy sites【4】.

CT Findings Suggestive of Malignancy

Management of Specific Effusion Types

Parapneumonic Effusion / Empyema

• Immediate tube thoracostomy is indicated when any of the following are present:

Malignant Effusion

• Asymptomatic patients: no therapeutic intervention required.
• Symptomatic patients:

Critical Pitfalls to Avoid

• Never remove >1.5 L in a single thoracentesis to prevent re‑expansion pulmonary edema【8】.
• Always measure pleural fluid pH in suspected infectious effusions to avoid missing a complicated parapneumonic effusion【7】.
• Intercostal tube drainage without pleurodesis results in a 100 % recurrence rate at one month【8】.
• Cytology alone detects only ~60 % of malignant effusions; if cytology is negative but suspicion remains, proceed to pleural biopsy【9】.

Evidence‑Based Management of Pleural Effusion

Clinical Assessment and Initial Decision‑Making

• Begin with a clinical assessment and chest radiography to identify likely transudative effusions (e.g., heart failure, cirrhosis, nephrotic syndrome) and treat the underlying condition without immediate thoracentesis unless atypical features or treatment failure are present. 10, 11
• Approximately 75 % of patients with pulmonary embolism and a pleural effusion experience pleuritic chest pain; parapneumonic effusions therefore require heightened clinical vigilance. 10, 12
• Tyrosine‑kinase inhibitors are now the most common drug‑related cause of exudative pleural effusions. 13
• An occupational history that specifically inquires about asbestos exposure should be obtained in every pleural‑effusion evaluation. 13

Imaging Strategy

• Perform thoracic ultrasound on every patient at presentation and before any pleural procedure; ultrasound guides interventions and reduces complication rates. 13, 14
• Ultrasound findings of diaphragmatic or parietal‑pleural nodularity are highly suggestive of malignant disease. 13
• When diagnostic aspiration is unsafe, proceed directly to computed tomography (CT) scanning. 13
• For suspected malignancy, obtain contrast‑enhanced CT of the chest, abdomen, and pelvis. 13
• For non‑malignant suspected etiologies, obtain a CT of the thorax with pleural contrast in the venous phase. 13

Thoracentesis Technique and Fluid Handling

• Use a fine‑bore (21 G) needle attached to a 50 mL syringe for diagnostic thoracentesis. 10, 11
• Send pleural fluid into both sterile vials and blood‑culture bottles to maximize microbiological yield. 10, 11

Routine Pleural Fluid Analysis

• Mandatory analyses include protein and lactate dehydrogenase (to apply Light’s criteria), pH (in all non‑purulent effusions when infection is suspected), Gram stain and culture, acid‑fast bacilli stain and culture, and cytology. 10, 11
• Apply Light’s criteria when pleural‑fluid protein concentrations are in the range of 25–35 g/L to differentiate exudates from transudates. 10, 11

Management of Malignant Pleural Effusions

• Asymptomatic patients: Do not perform therapeutic pleural interventions. 14, 15, 16
• Symptomatic patients – initial assessment: Perform large‑volume thoracentesis (up to 1.5 L) to evaluate symptom relief and lung‑expandability before definitive therapy. 14, 15, 16
• Expandable lung: Either an indwelling pleural catheter (IPC) or chemical pleurodesis (talc) is recommended as first‑line definitive treatment. 14, 15, 16
• Talc pleurodesis: Both talc poudrage and talc slurry are equally acceptable techniques. 14, 15, 16
• Non‑expandable lung, loculated effusion, or failed pleurodesis: Use an IPC rather than chemical pleurodesis. 14, 15, 16
• IPC‑associated infection: Treat with antibiotics without routine catheter removal; remove the catheter only if infection does not improve. 14, 15, 16
• Very short life expectancy: Repeat therapeutic pleural aspiration (1–1.5 L per session) provides palliation. 17

Approach to Undiagnosed Effusions After Initial Work‑up

• Re‑evaluate for treatable conditions such as tuberculosis, pulmonary embolism, lymphoma, IgG4‑related disease, and chronic heart failure. 13
• Obtain pleural tissue via ultrasound/CT‑guided core biopsy, closed pleural biopsy, or thoracoscopy when fluid analysis is nondiagnostic. 10, 11
• Consider watchful waiting with interval CT scans for persistent small effusions that are too tiny to sample safely. 13

Critical Pitfalls to Avoid

• Do not remove more than 1.5 L of fluid in a single thoracentesis to prevent re‑expansion pulmonary edema. 17
• Always measure pleural fluid pH in suspected infectious effusions to avoid missing a complicated parapneumonic effusion. 10, 11
• Intercostal tube drainage without concurrent pleurodesis results in an almost 100 % recurrence rate at one month. 17
• Cytology alone detects only about 60 % of malignant effusions; if cytology is negative but suspicion remains, proceed to pleural biopsy. 10, 11
• Perform CT imaging with fluid present whenever feasible, as this improves pleural visualization and helps identify optimal biopsy sites. 10, 11